Nine pharmaceutical companies including Bristol-Myers Squibb, GSK and Merck agreed to lower the prices that certain federal government programs and patients pay
Bristol-Myers SquibbBristol-Myers Squibb(US:BMY) WSJ·2025-12-19 21:09

Group 1 - Companies such as Bristol-Myers Squibb, GSK, and Merck are set to avoid potential U.S. tariffs [1]